Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Alessandro Rambaldi, Massimo Bernardi et al.|Blood Advances|2019Cited by 33
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06Chiara Caprioli, Alessandro Rambaldi, Federico Lussana et al.|Haematologica|2020Cited by 22
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)Silvia Salmoiraghi, Orietta Spinelli, Roberta Cavagna et al.|Cancers|2020Cited by 10
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)Tamara Intermesoli, Renato Bassan, Giovanni Rossi et al.|IrInSubria (University of Insubria)|2010Cited by 1
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06Chiara Caprioli, Alessandro Rambaldi, Federico Lussana et al.|Blood|2019Cited by 1